Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis

Blood

Volumn 103, Issue 10, 2004, Pages 3915-3923

  Kuijpers, Taco W ^a   Maianski, Nikolai A ^b   Tool, Anton T J ^b   Becker, Kolja ^b   Plecko, Barbara ^b   Valianpour, Fredoen ^b   Wanders, Ron J A ^b   Pereira, Rob ^b   Van Hove, Johan ^b   Verhoeven, Arthur J ^b   Roos, Dirk ^b   Baas, Frank ^b   Barth, Peter G ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; CASPASE; CD16 ANTIGEN; LIPOCORTIN 5; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEIN BAX;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BARTH SYNDROME; CELL MOTILITY; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; EOSINOPHIL; GENE; GENE MUTATION; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE ADHERENCE; MITOCHONDRIAL MEMBRANE; MOLECULAR RECOGNITION; NEUTROPHIL; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN TRANSPORT; TAZ GENE;

EID: 2342480420     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-11-3940     Document Type: Article

References (54)

1. Barth PG, Wanders RJ, Vreken P, Janssen EA, Lam J, Baas F. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J Inherit Metab Dis. 1999;22:555-567.
2. Barth PG, Scholte HR, Berden JA, et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci. 1983;62:327-355.
3. Kuijpers TW. Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death. Eur J Pediatr. 2002;161: S75-S82.
4. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 1995;85:532-540.
5. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000;407:784-788.
6. Giles KM, Hart SP, Haslett C, Rossi AG, Dransfield I. An appetite for apoptotic cells? Controversies and challenges. Br J Haematol. 2000;109:1-12.
7. Adams MJ, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
8. Thomberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312-1316.
9. Reed JC. Mechanisms of apoptosis. Am J Pathol. 2000;157:1415-1430.
10. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776.
11. Maianski NA, Mul FPJ, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor (G-CSF) inhibits in neutrophils the mitochondria-dependent activation of caspase-3. Blood. 2002;99:672-679.
12. Bolhuis PA, Hensels GW, Hulsebos TJ, Baas F, Barth PG. Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am J Hum Genet. 1991;48:481-485.
13. Bione S, d'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D. A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet. 1996;12:385-389.
14. Johnston J, Kelley RI, Feigenbaum A, et al. Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am J Hum Genet. 1997;61:1053-1058.
15. Cantlay AM, Shokrollahi K, Allen JT, Lunt PW, Newbury-Ecob RA, Steward CG. Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J Pediatr. 1999;135:311-315.
16. Neuwald AF. Barth syndrome may be due to an acyltransferase deficiency. Curr Biol. 1997;7: R465-R466.
17. Vreken P, Valianpour F, Nijtmans LG, et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun. 2000;279:378-382.
18. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJ. Deficiency of tetralinoleoylcardiolipin in Barth syndrome. Ann Neurol. 2002; 51:634-637.
19. Valianpour F, Wanders RJA, Barth PG, Overmars H, van Gennip AH. Quantitative and compositional study of cardiolipin in platelets by electron-spray ionization mass spectrometry: application for the identification of Barth syndrome patients. Clin Chem. 2002;48:1390-1397.
20. Valianpour F, Wanders RJA, Overmars H, et al. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060) - a study in cultured skin fibroblasts. J Pediatr. 2002;141:729-733.
21. Esposti MD. Lipids, cardiolipin and apoptosis: a greasy licence to kill. Cell Death Differ. 2002;9: 234-236.
22. Kuijpers TW, Malanski NA, Tool ATJ, et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood. 2003;101:5021-5024.
23. 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem. 1992; 209:267-273.
24. Williamson P, Christie A, Kohlin T, et al. Phospholipid scramblase activation pathways in lymphocytes. Biochemistry. 2001;40:8065-8072.
25. Hulzinga TW, de Haas M, Kleijer M, Nuijens JH, Roos D, von dem Bome AE. Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest. 1990;86:416-423.
26. Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease. J Clin Invest. 1994;93:1288-1292.
27. Kuijpers TW, Weening RS, Roos D. Laboratory workup for neutrophil dysfunctions: numerical and functional defects. J Immunol Methods. 1999;232:211-229.
28. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032-3043.
29. Bokoch GM. Chemoattractant signalling and leukocyte activation. Blood. 1996;86:1649-1660.
30. Huizinga TW, de Haas M, van Oers MH, et al. The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils. Br J Haematol. 1994;87:459-463.
31. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80:2012-2020.
32. van den Berg JM, Wijers F, Roos D, Kuijpers TW. Divergent effect of TNF-alpa on apoptosis of human neutrophils. J Leukoc Biol. 2001;69: 467-473.
33. Ørstavik RE, Naumova AK, et al. X chromosome inactivation in carriers of Barth syndrome. Am J Hum Genet. 1998;63:1457-1463.
34. Dransfield I, Stocks SC, Haslett C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood. 1995;85:3264-3273.
35. Kuwana T, Mackey MR, Perkins G, et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 2002;111:331-342.
36. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A. 2002;99:1259-1263.
37. Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol. 2002; 2:754-761.
38. McMillin JB, Dowhan W. Cardiolipin and apoptosis. Biochem Biophys Acta. 2002;1585:97-107.
39. Murphy BM, O'Neill AJ, Adrain C, Watson RW, Martin SJ. The apoptosome pathway to caspase activation in primary human neutrophils exhibits dramatically reduced requirements for cytochrome c. J Exp Med. 2003;197:625-632.
40. Maianski NA, Geissler J, Srinivasula S, Alnemri ES, Roos D, Kuijpers TW. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ. 2004;11: 143-153.
41. Bevers EM, Comfurius P, Dekkers DW, Zwaal RF. Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta. 1999; 1439:317-330.
42. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood. 1996;87: 1409-1415.
43. Stout JG, Basse F, Luhm RA, Weiss HJ, Wiedmer T, Sims PJ. Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest. 1997;99:2232-2238.
44. Dekkers DW, Comfurius P, Vuist WM, et al. Impaired Ca2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome. Blood. 1998;91:2133-2138.
45. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest. 1985;75:1965-1972.
46. Wang RH, Phillips G Jr, Medof ME, Mold C. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest. 1993;92:1326-1335.
47. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
48. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000;405:85-90.
49. Henson PM, Bratton DL, Fadok VA. The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol. 2001;2:627-633.
50. Dillon SR, Macini M, Rosen A, Schlissel MS. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol. 2000;164:1322-32.
51. Van den Eijnde SM, van den Hoff MJB, Reutelingsberger CPM, et al. Transient expression of phosphatidylserine at cell-cell contact areas is requirted for myotube formation. J Cell Sci. 2001; 114:3631-3642.
52. Chang MK, Bergmark C, Laurila A, et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A. 1999;96:6353-6358.
53. Balasubramanian K, Bevers EM, Willems GM, Schroft AJ. Binding of annexin V to membrane products of lipid peroxidation. Biochemistry. 2001; 40:8672-8676.
54. Vaz FM, Houtkooper RH, Vallanpour F, Barth PG, Wanders RJ. Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism. J Biol Chem. 2003;278:43089-43094.